TapewireFind a company

organization · Reporting owner

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC

Disclosed activity across 2 companies

Tapewire entity
116734
SEC CIK
0001435899

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Movella Holdings Inc.MVLA · Entity 10990310% ownerFebruary 10, 2023February 17, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Movella Holdings Inc.

Report date February 10, 2023 · Filed February 17, 2023

Jointly reported with KPCB XIII Associates, LLC

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeIndirectSee footnote5,189,011 Reported balance Holding disclosure · report date 2023-02-10 · row 1 Holding and transaction disclosures are not merged.
1 source row

Row 1 · Balance 5,189,011

F1: Consists of 5,189,011 shares of common stock, par value $0.00001 per share, of Movella Holdings Inc. held by KPCB Holdings, Inc. ("KPCB Holdings"), as nominee for Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII"). The managing member of KPCB XIII is KPCB XIII Associates, LLC ("Associates"). The voting and dispositive control over the shares is shared by several individual managing directors of Associates, none of whom has veto power. No natural person controls investment or voting decisions with respect to the shares held by KPCB Holdings.

Filing footnotes · ownership attribution and instrument terms

F1: Consists of 5,189,011 shares of common stock, par value $0.00001 per share, of Movella Holdings Inc. held by KPCB Holdings, Inc. ("KPCB Holdings"), as nominee for Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII"). The managing member of KPCB XIII is KPCB XIII Associates, LLC ("Associates"). The voting and dispositive control over the shares is shared by several individual managing directors of Associates, none of whom has veto power. No natural person controls investment or voting decisions with respect to the shares held by KPCB Holdings.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Progyny, Inc.

Report date June 21, 2021 · Filed June 22, 2021

Jointly reported with KPCB XIII Associates, LLC

Section 16 reporting ended · disclosed 2021-06-22. Current position is not established by this disclosure.

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect7,406,115 Reported balance After 2021-06-21 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 1 · 2021-06-21 · Other · Disposed 1,398,900 · Balance 7,406,115

F1: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII") without consideration to its members (the "Fund Distribution"). Excludes 101,100 shares of Common Stock for which a change in the form of beneficial ownership for individuals and entities associated with Kleiner Perkins Caufield & Byers occurred.

F2: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 535,248 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

Common StockSEC Table I · non-derivativeIndirectSee footnote467,415 Reported balance After 2021-06-21 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 2 · 2021-06-21 · Other · Acquired 467,415 · Balance 467,415

F3: Represents a change in the form of ownership as a result of the receipt by XIII Associates of shares in the Fund Distribution.

F4: Consists of 467,415 shares of Common Stock of the Issuer held by XIII Associates.

Common StockSEC Table I · non-derivativeIndirectSee footnote29,494 Reported balance After 2021-06-21 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source row

Row 3 · 2021-06-21 · Other · Disposed 437,921 · Balance 29,494

F5: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by XIII Associates without consideration to its members.

F6: Consists of 29,494 shares of Common Stock of the Issuer held by XIII Associates.

Filing footnotes · ownership attribution and instrument terms

F1: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII") without consideration to its members (the "Fund Distribution"). Excludes 101,100 shares of Common Stock for which a change in the form of beneficial ownership for individuals and entities associated with Kleiner Perkins Caufield & Byers occurred.

F2: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 535,248 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

F3: Represents a change in the form of ownership as a result of the receipt by XIII Associates of shares in the Fund Distribution.

F4: Consists of 467,415 shares of Common Stock of the Issuer held by XIII Associates.

F5: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by XIII Associates without consideration to its members.

F6: Consists of 29,494 shares of Common Stock of the Issuer held by XIII Associates.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 21, 2021 Filed Jun 22, 2021 23:43 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 437,921 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-084287 · tm2120428d1_4seq1.xml · nonDerivative · entry 3

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 29,494

F5 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by XIII Associates without consideration to its members.

F6 · ownership.nature: Consists of 29,494 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
June 21, 2021 Filed Jun 22, 2021 23:43 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 467,415 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-084287 · tm2120428d1_4seq1.xml · nonDerivative · entry 2

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 467,415

F3 · kind: Represents a change in the form of ownership as a result of the receipt by XIII Associates of shares in the Fund Distribution.

F4 · ownership.nature: Consists of 467,415 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
June 21, 2021 Filed Jun 22, 2021 23:43 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 1,398,900 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-084287 · tm2120428d1_4seq1.xml · nonDerivative · entry 1

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,406,115

F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII") without consideration to its members (the "Fund Distribution"). Excludes 101,100 shares of Common Stock for which a change in the form of beneficial ownership for individuals and entities associated with Kleiner Perkins Caufield & Byers occurred.

F2 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 535,248 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

Read SEC document
April 15, 2021 Filed Apr 19, 2021 23:24 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock Warrants (right to buy) · Derivative 284,998 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001104659-21-052085 · tm2113432d1_4.xml · derivative · entry 6

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 284,998 shares

Expires 2024-12-18

F8 · ownership.direct: The warrant is directly held by KPCB XIII. The warrant is held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIII is XIII Associates. The voting and dispositive control over the warrant is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 20,597 shares of Common Stock underlying the warrant beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such warrant. any other purpose. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Read SEC document
April 15, 2021 Filed Apr 19, 2021 23:24 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock Warrants (right to buy) · Derivative 242,248 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001104659-21-052085 · tm2113432d1_4.xml · derivative · entry 5

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 242,248 shares

Expires 2023-09-06

F7 · ownership.direct: The warrant is directly held by KPCB XIII. The warrant is held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIII is XIII Associates. The voting and dispositive control over the warrant is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 17,508 shares of Common Stock underlying the warrant beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such warrant. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Read SEC document
April 15, 2021 Filed Apr 19, 2021 23:24 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 9,799 $50.32 $493,085.68
Disclosure

SEC source: 0001104659-21-052085 · tm2113432d1_4.xml · nonDerivative · entry 4

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,805,015

F5 · kind: On April 15, 2021, KPCB XIII exercised a warrant to purchase 284,998 shares of the Issuer's Common Stock for $1.73 per share. KPCB XIII paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 9,799 of the warrant shares to pay the exercise price and issuing to KPCB XIII the remaining 275,199 shares. Excludes 708 similarly withheld shares of Common Stock that were beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

F6 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is XIII Associates. The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 636,348 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

Read SEC document
April 15, 2021 Filed Apr 19, 2021 23:24 UTC Progyny, Inc. PGNY · Entity 4521 SaleCommon Stock 8,328 $50.32 $419,064.96
Disclosure

SEC source: 0001104659-21-052085 · tm2113432d1_4.xml · nonDerivative · entry 3

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,814,814

F3 · kind: On April 15, 2021, KPCB XIII exercised a warrant to purchase 242,248 shares of the Issuer's Common Stock for $1.73 per share. KPCB XIII paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 8,328 of the warrant shares to pay the exercise price and issuing to KPCB XIII the remaining 233,920 shares. Excludes 602 similarly withheld shares of Common Stock that were beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

F4 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is XIII Associates. The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 637,056 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

Read SEC document
April 15, 2021 Filed Apr 19, 2021 23:24 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 284,998 $1.73 $493,046.54
Disclosure

SEC source: 0001104659-21-052085 · tm2113432d1_4.xml · nonDerivative · entry 2

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,823,142

F2 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is XIII Associates. The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 637,658 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

Read SEC document
April 15, 2021 Filed Apr 19, 2021 23:24 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 242,248 $1.73 $419,089.04
Disclosure

SEC source: 0001104659-21-052085 · tm2113432d1_4.xml · nonDerivative · entry 1

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,538,144

F1 · ownership.direct: The shares are directly held by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 617,061 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

Read SEC document
January 22, 2021 Filed Apr 1, 2021 23:15 UTC Amendment Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 489,038 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-045759 · tm2111951-2_4a.xml · nonDerivative · entry 3

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 90,310

F1 · date: On January 26, 2021, the Reporting Persons filed a Form 4 which inadvertently reported the Transaction Date as January 22, 2020. In fact, as reported in this amendment, the Transaction Date was January 22, 2021.

F6 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by XIII Associates without consideration to its members.

F7 · ownership.nature: Consists of 90,310 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
January 22, 2021 Filed Apr 1, 2021 23:15 UTC Amendment Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 522,904 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-045759 · tm2111951-2_4a.xml · nonDerivative · entry 2

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 579,348

F1 · date: On January 26, 2021, the Reporting Persons filed a Form 4 which inadvertently reported the Transaction Date as January 22, 2020. In fact, as reported in this amendment, the Transaction Date was January 22, 2021.

F4 · kind: Represents a change in the form of ownership as a result of the receipt by XIII Associates of shares in the Fund Distribution.

F5 · ownership.nature: Consists of 579,348 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
January 22, 2021 Filed Apr 1, 2021 23:15 UTC Amendment Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 1,398,900 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-045759 · tm2111951-2_4a.xml · nonDerivative · entry 1

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,295,896

F1 · date: On January 26, 2021, the Reporting Persons filed a Form 4 which inadvertently reported the Transaction Date as January 22, 2020. In fact, as reported in this amendment, the Transaction Date was January 22, 2021.

F2 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII") without consideration to its members (the "Fund Distribution"). Excludes 101,100 shares of Common Stock for which a change in the form of beneficial ownership for individuals and entities associated with Kleiner Perkins Caufield & Byers occurred.

F3 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 599,553 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

Read SEC document
January 07, 2021 Filed Apr 1, 2021 23:16 UTC Amendment Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 489,038 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-045760 · tm2111951-3_4a.xml · nonDerivative · entry 3

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 56,444

F1 · date: On January 11, 2021, the Reporting Persons filed a Form 4 which inadvertently reported the Transaction Date as January 7, 2020. In fact, as reported in this amendment, the Transaction Date was January 7, 2021.

F6 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by XIII Associates without consideration to its members.

F7 · ownership.nature: Consists of 56,444 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
January 07, 2021 Filed Apr 1, 2021 23:16 UTC Amendment Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 522,904 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-045760 · tm2111951-3_4a.xml · nonDerivative · entry 2

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 545,482

F1 · date: On January 11, 2021, the Reporting Persons filed a Form 4 which inadvertently reported the Transaction Date as January 7, 2020. In fact, as reported in this amendment, the Transaction Date was January 7, 2021.

F4 · kind: Represents a change in the form of ownership as a result of the receipt by XIII Associates of shares in the Fund Distribution.

F5 · ownership.nature: Consists of 545,482 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
January 07, 2021 Filed Apr 1, 2021 23:16 UTC Amendment Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 1,398,900 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-045760 · tm2111951-3_4a.xml · nonDerivative · entry 1

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,694,796

F1 · date: On January 11, 2021, the Reporting Persons filed a Form 4 which inadvertently reported the Transaction Date as January 7, 2020. In fact, as reported in this amendment, the Transaction Date was January 7, 2021.

F2 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII") without consideration to its members (the "Fund Distribution"). Excludes 101,100 shares of Common Stock for which a change in the form of beneficial ownership for individuals and entities associated with Kleiner Perkins Caufield & Byers occurred.

F3 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 700,653 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

Read SEC document
December 30, 2020 Filed Jan 4, 2021 22:39 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 326,025 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-000401 · tm211556d2_form4.xml · nonDerivative · entry 3

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 22,578

F5 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by XIII Associates without consideration to its members.

F6 · ownership.nature: Consists of 22,578 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
December 30, 2020 Filed Jan 4, 2021 22:39 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 348,603 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-000401 · tm211556d2_form4.xml · nonDerivative · entry 2

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 348,603

F3 · kind: Represents a change in the form of ownership as a result of the receipt by XIII Associates of shares in the Fund Distribution.

F4 · ownership.nature: Consists of 348,603 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
December 30, 2020 Filed Jan 4, 2021 22:39 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 932,600 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-000401 · tm211556d2_form4.xml · nonDerivative · entry 1

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,093,696

F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII") without consideration to its members (the "Fund Distribution"). Excludes 67,400 shares of Common Stock for which a change in the form of beneficial ownership for individuals and entities associated with Kleiner Perkins Caufield & Byers occurred.

F2 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 801,753 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

Read SEC document
November 30, 2020 Filed Dec 2, 2020 23:43 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 522,904 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-131677 · tm2037533d1_form4.xml · nonDerivative · entry 3

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F5 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by XIII Associates without consideration to its members.

F6 · ownership.nature: XIII Associates holds no shares of Common Stock of the Issuer following the pro-rata in-kind distribution of such shares to its members.

Read SEC document
November 30, 2020 Filed Dec 2, 2020 23:43 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 522,904 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-131677 · tm2037533d1_form4.xml · nonDerivative · entry 2

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 522,904

F3 · kind: Represents a change in the form of ownership as a result of the receipt by XIII Associates of shares in the Fund Distribution.

F4 · ownership.nature: Consists of 522,904 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
November 30, 2020 Filed Dec 2, 2020 23:43 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 1,398,900 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-131677 · tm2037533d1_form4.xml · nonDerivative · entry 1

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,026,296

F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII") without consideration to its members (the "Fund Distribution"). Excludes 101,100 shares of Common Stock for which a change in the form of beneficial ownership for individuals and entities associated with Kleiner Perkins Caufield & Byers occurred.

F2 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 869,153 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

Read SEC document
November 13, 2020 Filed Nov 17, 2020 23:43 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 593,197 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-126469 · tm2036307-1_4.xml · nonDerivative · entry 3

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

F5 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by XIII Associates without consideration to its members.

F6 · ownership.nature: XIII Associates holds no shares of Common Stock of the Issuer following the pro-rata in-kind distribution of such shares to its members.

Read SEC document
November 13, 2020 Filed Nov 17, 2020 23:43 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 522,904 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-126469 · tm2036307-1_4.xml · nonDerivative · entry 2

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 593,197

F3 · kind: Represents a change in the form of ownership as a result of the receipt by XIII Associates of shares in the Fund Distribution.

F4 · ownership.nature: Consists of 593,197 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
November 13, 2020 Filed Nov 17, 2020 23:43 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 1,398,900 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-126469 · tm2036307-1_4.xml · nonDerivative · entry 1

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,425,196

F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII") without consideration to its members (the "Fund Distribution"). Excludes 101,100 shares of Common Stock for which a change in the form of beneficial ownership for individuals and entities associated with Kleiner Perkins Caufield & Byers occurred.

F2 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 970,253 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

Read SEC document
August 19, 2020 Filed Aug 21, 2020 22:53 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 1,008,047 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-097707 · tm2029224d1_4.xml · nonDerivative · entry 3

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 70,293

F5 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by XIII Associates without consideration to its members.

F6 · ownership.nature: Consists of 70,293 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
August 19, 2020 Filed Aug 21, 2020 22:53 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 1,078,340 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-097707 · tm2029224d1_4.xml · nonDerivative · entry 2

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 1,078,340

F3 · kind: Represents a change in the form of ownership as a result of the receipt by XIII Associates of shares in the Fund Distribution.

F4 · ownership.nature: Consists of 1,078,340 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
August 19, 2020 Filed Aug 21, 2020 22:53 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 2,797,800 $0.00 $0.00
Disclosure

SEC source: 0001104659-20-097707 · tm2029224d1_4.xml · nonDerivative · entry 1

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,824,096

F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII") without consideration to its members (the "Fund Distribution"). Excludes 202,200 shares of Common Stock for which a change in the form of beneficial ownership for individuals and entities associated with Kleiner Perkins Caufield & Byers occurred.

F2 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 1,071,353 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

Read SEC document
January 22, 2020 Filed Jan 26, 2021 22:24 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 489,038 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-007732 · tm214251-1_4seq1.xml · nonDerivative · entry 3

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 90,310

F5 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by XIII Associates without consideration to its members.

F6 · ownership.nature: Consists of 90,310 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
January 22, 2020 Filed Jan 26, 2021 22:24 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 522,904 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-007732 · tm214251-1_4seq1.xml · nonDerivative · entry 2

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 579,348

F3 · kind: Represents a change in the form of ownership as a result of the receipt by XIII Associates of shares in the Fund Distribution.

F4 · ownership.nature: Consists of 579,348 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
January 22, 2020 Filed Jan 26, 2021 22:24 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 1,398,900 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-007732 · tm214251-1_4seq1.xml · nonDerivative · entry 1

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,295,896

F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII") without consideration to its members (the "Fund Distribution"). Excludes 101,100 shares of Common Stock for which a change in the form of beneficial ownership for individuals and entities associated with Kleiner Perkins Caufield & Byers occurred.

F2 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 599,553 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

Read SEC document
January 07, 2020 Filed Jan 11, 2021 23:06 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 489,038 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-003083 · tm212852-1_4seq1.xml · nonDerivative · entry 3

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 56,444

F5 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by XIII Associates without consideration to its members.

F6 · ownership.nature: Consists of 56,444 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
January 07, 2020 Filed Jan 11, 2021 23:06 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 522,904 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-003083 · tm212852-1_4seq1.xml · nonDerivative · entry 2

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 545,482

F3 · kind: Represents a change in the form of ownership as a result of the receipt by XIII Associates of shares in the Fund Distribution.

F4 · ownership.nature: Consists of 545,482 shares of Common Stock of the Issuer held by XIII Associates.

Read SEC document
January 07, 2020 Filed Jan 11, 2021 23:06 UTC Progyny, Inc. PGNY · Entity 4521 OtherCommon Stock 1,398,900 $0.00 $0.00
Disclosure

SEC source: 0001104659-21-003083 · tm212852-1_4seq1.xml · nonDerivative · entry 1

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,694,796

F1 · kind: Represents a pro-rata in-kind distribution of Common Stock of the Issuer by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII") without consideration to its members (the "Fund Distribution"). Excludes 101,100 shares of Common Stock for which a change in the form of beneficial ownership for individuals and entities associated with Kleiner Perkins Caufield & Byers occurred.

F2 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee." The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 700,653 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares.

Read SEC document
October 29, 2019 Filed Oct 30, 2019 01:17 UTC Progyny, Inc. PGNY · Entity 4521 ConversionCommon Stock Warrants (right to buy) · Derivative 284,998 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001209191-19-054418 · doc4.xml · derivative · entry 8

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 284,998

Underlying: Common Stock · 284,998 shares

Expires 2024-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants.

F8 · ownership.direct: The warrant is directly held by KPCB XIII. The warrant is held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIII is XIII Associates. The voting and dispositive control over the warrant is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 20,597 shares of Series B Preferred Stock underlying the warrant beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such warrant. any other purpose. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Read SEC document
October 29, 2019 Filed Oct 30, 2019 01:17 UTC Progyny, Inc. PGNY · Entity 4521 ConversionSeries B Warrant (right to buy) · Derivative 284,998 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001209191-19-054418 · doc4.xml · derivative · entry 7

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Series B Preferred Stock · 284,998 shares

Expires 2024-12-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants.

F8 · ownership.direct: The warrant is directly held by KPCB XIII. The warrant is held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIII is XIII Associates. The voting and dispositive control over the warrant is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 20,597 shares of Series B Preferred Stock underlying the warrant beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such warrant. any other purpose. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Read SEC document
October 29, 2019 Filed Oct 30, 2019 01:17 UTC Progyny, Inc. PGNY · Entity 4521 ConversionCommon Stock Warrants (right to buy) · Derivative 242,248 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001209191-19-054418 · doc4.xml · derivative · entry 6

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 242,248

Underlying: Common Stock · 242,248 shares

Expires 2023-09-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants.

F7 · ownership.direct: The warrant is directly held by KPCB XIII. The warrant is held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIII is XIII Associates. The voting and dispositive control over the warrant is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 17,508 shares of Series B Preferred Stock underlying the warrant beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such warrant. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Read SEC document
October 29, 2019 Filed Oct 30, 2019 01:17 UTC Progyny, Inc. PGNY · Entity 4521 ConversionSeries B Warrant (right to buy) · Derivative 242,248 $0.00 Strike: $1.73 $0.00
Disclosure

SEC source: 0001209191-19-054418 · doc4.xml · derivative · entry 5

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Series B Preferred Stock · 242,248 shares

Expires 2023-09-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · kind: The Issuer's Preferred Stock warrants automatically converted into warrants to purchase Common Stock immediately prior to the closing of the Issuer's initial public offering without payment or further consideration. The transaction is listed solely for the purpose of reporting the change in the shares underlying the warrants.

F7 · ownership.direct: The warrant is directly held by KPCB XIII. The warrant is held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIII is XIII Associates. The voting and dispositive control over the warrant is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 17,508 shares of Series B Preferred Stock underlying the warrant beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such warrant. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Read SEC document
October 29, 2019 Filed Oct 30, 2019 01:17 UTC Progyny, Inc. PGNY · Entity 4521 ConversionSeries B Preferred Stock · Derivative 10,753,784 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-054418 · doc4.xml · derivative · entry 4

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 10,753,784 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on October 29, 2019.

F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on October 29, 2019.

F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on October 29, 2019.

F5 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIII is XIII Associates. The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 777,187 shares of Series B Preferred Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Read SEC document
October 29, 2019 Filed Oct 30, 2019 01:17 UTC Progyny, Inc. PGNY · Entity 4521 ConversionSeries A Preferred Stock · Derivative 6,149,084 $0.00 $0.00
Disclosure

SEC source: 0001209191-19-054418 · doc4.xml · derivative · entry 3

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,149,084 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on October 29, 2019.

F1 · derivative.exercise_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on October 29, 2019.

F1 · derivative.expiration_date: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on October 29, 2019.

F4 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIII is XIII Associates. The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 444,401 shares of Series A Preferred Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Read SEC document
October 29, 2019 Filed Oct 30, 2019 01:17 UTC Progyny, Inc. PGNY · Entity 4521 ConversionCommon Stock 10,753,784 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-054418 · doc4.xml · nonDerivative · entry 2

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,621,896

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on October 29, 2019.

F3 · ownership.direct: The shares are directly held by KPCB XIII. All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIII is XIII Associates. The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 1,273,553 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Read SEC document
October 29, 2019 Filed Oct 30, 2019 01:17 UTC Progyny, Inc. PGNY · Entity 4521 ConversionCommon Stock 6,149,084 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-19-054418 · doc4.xml · nonDerivative · entry 1

KLEINER PERKINS CAUFIELD & BYERS XIII, LLC · CIK 0001435899 · 10% owner

KPCB XIII Associates, LLC · CIK 0001500595 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,868,112

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of Issuer's common stock, without payment of additional consideration, on a one-for-one basis, immediately upon the closing of the Issuer's initial public offering on October 29, 2019.

F2 · ownership.direct: The shares are directly held by Kleiner Perkins Caufield & Byers XIII, LLC ("KPCB XIII"). All shares are held for convenience in the name of "KPCB Holdings, Inc., as nominee". The managing member of KPCB XIII is KPCB XIII Associates, LLC ("XIII Associates"). The voting and dispositive control over the shares is shared by individual managing directors of XIII Associates, none of whom has veto power. Excludes 496,366 shares of Common Stock beneficially owned by individuals and entities associated with Kleiner Perkins Caufield & Byers and held for convenience in the name of "KPCB Holdings, Inc. as nominee," for the accounts of such individuals and entities who each exercise their own voting and dispositive control over such shares. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.